Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Treasury Shares: 2009-2025

Historic Treasury Shares for Argan (AGX) over the last 9 years, with Oct 2025 value amounting to $113.6 million.

  • Argan's Treasury Shares rose 10.55% to $113.6 million in Q4 2025 from the same period last year, while for Oct 2025 it was $113.6 million, marking a year-over-year increase of 10.55%. This contributed to the annual value of $105.6 million for FY2025, which is 8.32% up from last year.
  • Latest data reveals that Argan reported Treasury Shares of $2.0 million as of Q4 2025, which was up 195,387.90% from $1,000 recorded in Q3 2025.
  • Over the past 5 years, Argan's Treasury Shares peaked at $2.6 million during Q1 2024, and registered a low of $1,000 during Q3 2025.
  • In the last 3 years, Argan's Treasury Shares had a median value of $131,222 in 2023 and averaged $761,995.
  • Data for Argan's Treasury Shares shows a peak YoY spiked of 61,733.33% (in 2022) over the last 5 years.
  • Quarterly analysis of 5 years shows Argan's Treasury Shares stood at $33,000 in 2021, then spiked by 61,733.33% to $83.7 million in 2022, then climbed by 11.80% to $93.5 million in 2023, then climbed by 9.85% to $102.7 million in 2024, then increased by 10.55% to $113.6 million in 2025.
  • Its Treasury Shares stands at $113.6 million for Q4 2025, versus $114.5 million for Q3 2025 and $114.0 million for Q2 2025.